|
Mar 26
|
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
|
|
Mar 15
|
Gain Therapeutics to Present at Public Ventures Discovery Day
|
|
Mar 5
|
EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease
|
|
Mar 5
|
Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson’s Disease
|
|
Dec 4
|
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research
|